All In MedTech

Device Trial Radar · NCT04952909

The ShortCut™ Study Protocol

A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Clinical Study to Demonstrate the Safety and Effectiveness of the ShortCut™ Device (The ShortCut™ Study)

Last checked: Nov 19, 2026Latest source record: Feb 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

60

Actual

Start

Jan 21, 2022

Primary completion

Sep 30, 2023

Study completion Dec 31, 2023

Sponsor

Lead sponsor
Pi-cardiaNot on our public-company list
Sponsor type
Industry
First posted
Jul 7, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Clinical Study to Demonstrate the Safety and Effectiveness of the ShortCut™ device for splitting bioprosthetic aortic valve leaflets in patients who are presented for a valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) procedure for an approved ViV indication, and who are at risk for TAVR-induced coronary artery ostium obstruction.

Conditions

  • Risk of Coronary Obstruction Following Transcatheter Aortic Valve Replacement (TAVR) Procedure

Interventions

  • ShortCut™Device

    Splitting bioprosthetic aortic valve leaflets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. (Number of Patients With) ShortCut™ Device- and/or ShortCut™ Procedure-related Mortality and All Cause StrokeTime frame: Discharge or at 7 days post-procedure, whichever occurs first
  2. (Number of Patients With) Leaflet Splitting Success Using the ShortCut™ DeviceTime frame: Intra-procedure

Locations

23 sites in 5 countries. Site status is shown where the registry gives one.

  • Tucson Medical Center

    Tucson, Arizona

  • Smidt Heart Institute Cedars-Sinai Medical

    Los Angeles, California

  • Kaiser Permanente - San Francisco Medical Center

    San Francisco, California

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.